Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the equity of access to the shingles vaccine.

Previously, the shingles vaccine was available to people turning 65 and 70 years old, up until their 80^th birthday, and to severely immunosuppressed individuals aged 50 years old and over.

As of 1 September 2025, approximately 300,000 more people have become eligible for shingles vaccination, with all severely immunosuppressed individuals aged 18 years old and over now being eligible for the shingles vaccine. Individuals who are severely immunosuppressed are most at risk of serious illness and complications from shingles, and so the decision has been made to follow the advice of the Joint Committee on Vaccination and Immunisation (JCVI), to lower the age of eligibility to protect the most vulnerable.

For immunocompetent individuals, the current offering to adults aged 65 and 70 years old was agreed by the Department, the UK Health Security Agency, and NHS England. This decision was made following the JCVI’s advice, an assessment of the effective use of National Health Service resources, and careful consideration of individual risk and population benefit.

Analysis shows that the difference in risk and vaccine effectiveness between an individual aged 66 to 69 years old and a 70-year-old is likely to be marginal. This was taken into consideration when planning the expansion of the vaccination programme for immunocompetent adults, which maintains the original offer for those turning 70 years old while also providing another cohort with the opportunity for vaccination.